Viking Global Investors LP A Tyr Pharma Inc Transaction History

Viking Global Investors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.07 - $4.66 $1.8 Million - $2.74 Million	-587,444 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.17 - $7.06 $777,209 - $2.53 Million	358,161 Added 156.21%	587,444 $1.65 Million
Q3 2019 Nov 13, 2019	BUY	$2.8 - $5.46 $641,992 - $1.25 Million	229,283 New	229,283 $802,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

Stay updated on Viking Global Investors LP with notifications on news.